Please wait while the formulary information is being retrieved.
CEQUA (cyclosporine)
- Keratoconjunctivitis sicca
0.09 % eye drops in a dropperette
- Instill 1 drop into affected eye(s) by ophthalmic route 2 times per day approximately 12 hours apart
Keratoconjunctivitis sicca
- Instill 1 drop into right eye by ophthalmic route every 12 hours
- Instill 1 drop into left eye by ophthalmic route every 12 hours
- Instill 1 drop into both eyes by ophthalmic route every 12 hours
- Instill 1 drop into both eyes by ophthalmic route 2 times per day approximately 12 hours apart
- Instill 1 drop into right eye by ophthalmic route 2 times per day approximately 12 hours apart
- Instill 1 drop into left eye by ophthalmic route 2 times per day approximately 12 hours apart
- Instill 1 drop into affected eye(s) by ophthalmic route 2 times per day approximately 12 hours apart
- Instill 1 drop into affected eye(s) by ophthalmic route every 12 hours
- None
Contraindicated
- None
Severe
Moderate
- None
- Ocular infection
Contraindicated
- None
Severe
Moderate
- None
CEQUA (cyclosporine)
- Keratoconjunctivitis sicca
- None
- Ocular irritation
- Ocular pain
More Frequent
Severe
Less Severe
- None
- Blurred vision
- Conjunctival hyperemia
- Eye tearing
- Ocular discharge
- Ocular redness
- Visual changes
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Bacterial keratitis
Less Severe
- Foreign body sensation of eye
- Ocular itching
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Cyclosporine (Ophth)
Safety and efficacy not established age less than 16 years.
- 1 Day – 16 Years
- Safety and efficacy not established age less than 16 years.
Cyclosporine (ophthalmic)
- Severity Level:
2
- Additional Notes: Systemic absorption not detected, fetal exposure not expected
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Cyclosporine (ophth)
Excretion in human milk after topical treatment has not been investigated
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Excretion in human milk after topical treatment has not been investigated |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Keratoconjunctivitis sicca | |
| H16.22 | Keratoconjunctivitis sicca, not specified as sjogren's |
| H16.221 | Keratoconjunctivitis sicca, not specified as sjogren's, right eye |
| H16.222 | Keratoconjunctivitis sicca, not specified as sjogren's, left eye |
| H16.223 | Keratoconjunctivitis sicca, not specified as sjogren's, bilateral |
| H16.229 | Keratoconjunctivitis sicca, not specified as sjogren's, unspecified eye |
| M35.01 | Sicca syndrome with keratoconjunctivitis |
| 0-9 | A-Z |
|---|---|
| H16.22 | Keratoconjunctivitis sicca, not specified as sjogren's |
| H16.221 | Keratoconjunctivitis sicca, not specified as sjogren's, right eye |
| H16.222 | Keratoconjunctivitis sicca, not specified as sjogren's, left eye |
| H16.223 | Keratoconjunctivitis sicca, not specified as sjogren's, bilateral |
| H16.229 | Keratoconjunctivitis sicca, not specified as sjogren's, unspecified eye |
| M35.01 | Sicca syndrome with keratoconjunctivitis |
Formulary Reference Tool